Alector, Inc. (ALEC) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Alector, Inc. (ALEC) closed at USD 1.88 on 2026-10-14, a change of +25.3 % over the past year, with a market capitalization of USD 213.26M.

Alector, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Alector, Inc. key figures

Previous close

USD 1.88 (2026-10-14)

1-year change

+25.3 %

Market cap

USD 213.26M

Enterprise value

USD 73.22M

P/E ratio (trailing)

-1.74

P/E ratio (forward)

-2.60

EPS (trailing)

-1.10

EPS (forward)

-0.73

PEG ratio

n/a

Price to book

-21.46

Revenue growth

-57.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.35

Employees

103

Analyst consensus (third-party)

hold

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Alector, Inc.

Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson's disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer's disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson's disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including Latozinemab and Nivisnebart. The company was founded in 2013 and is headquartered in South San Francisco, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Alector, Inc. and compare it with other stocks.